World's Best Scientists 2026 revealed!
Maria Virginia Villegas

Maria Virginia Villegas

D-Index & Metrics

Microbiology

D-Index
49
Citations
17743
World Ranking
4512
National Ranking
5

Maria Virginia Villegas publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Maria Virginia Villegas sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 117 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Maria Virginia Villegas D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Maria Virginia Villegas sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 49 D-Index — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Maria Virginia Villegas is affiliated with El Bosque University in Colombia and focuses research efforts primarily on microbiology, antimicrobial resistance, and related medical fields.

The scientist's recent papers include the following:

  • Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study (2021, The Lancet Infectious Diseases)
  • Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study (2023, The Lancet Microbe)
  • Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections (2022, International Journal of Antimicrobial Agents)
  • Update on the epidemiology of carbapenemases in Latin America and the Caribbean (2020, Expert Review of Anti-infective Therapy)
  • The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa (2021, European Journal of Clinical Microbiology & Infectious Diseases)

The scientist has collaborated frequently with the following coauthors:

  • Christian Pallares
  • Elsa De La Cadena
  • Juan Carlos García-Betancur
  • Souha S. Kanj
  • José M. Munita

Common publication venues for the scientist include:

  • Antibiotics
  • JAC-Antimicrobial Resistance
  • Open Forum Infectious Diseases
  • Antimicrobial Agents and Chemotherapy
  • Journal of Antimicrobial Chemotherapy

The primary fields of study for Maria Virginia Villegas encompass:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine
  • Immunology and Microbiology

More specific subfields of research focus on:

  • Applied Microbiology and Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Clinical Biochemistry
  • Epidemiology

Key topics addressed in the scientist's work include:

  • Antibiotic Use and Resistance
  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Pharmaceutical Practices and Patient Outcomes
  • Patient Satisfaction in Healthcare

Best Publications

  • Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

    Evelina Tacconelli;Elena Carrara;Alessia Savoldi;Stephan Harbarth

  • Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

    L Silvia Munoz-Price;L Silvia Munoz-Price;Laurent Poirel;Robert A Bonomo;Robert A Bonomo;Mitchell J Schwaber

  • Genetic Structures at the Origin of Acquisition of the β-Lactamase blaKPC Gene

    Thierry Naas;Gaelle Cuzon;Maria-Virginia Villegas;Marie-Frédérique Lartigue

  • Acinetobacter outbreaks, 1977-2000.

    Maria Virginia Villegas;Alan I Hartstein

  • Antibiotic stewardship in low- and middle-income countries: the same but different?

    J.A. Cox;E. Vlieghe;M. Mendelson;H. Wertheim

  • First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing β-Lactamase

    Maria Virginia Villegas;Karen Lolans;Adriana Correa;Juan Nicolas Kattan

  • Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid

    Seok Ming Toh;Liqun Xiong;Cesar A. Arias;Cesar A. Arias;Maria V. Villegas

  • Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene.

    Gaëlle Cuzon;Thierry Naas;HaVy Truong;Maria-Virginia Villegas

  • First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South America

    Maria Virginia Villegas;Karen Lolans;Adriana Correa;Carlos Jose Suarez

  • The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae

    Laurent Poirel;Aurélie Jayol;Séverine Bontron;Maria-Virginia Villegas

  • Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.

    Minggui Wang;Michelle Earley;Liang Chen;Blake M Hanson

  • Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study

    Unknown

  • A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail

    Debra A Goff;Ravina Kullar;Ellie J C Goldstein;Mark Gilchrist

  • Resistance to Colistin Associated with a Single Amino Acid Change in Protein PmrB among Klebsiella pneumoniae Isolates of Worldwide Origin

    Aurélie Jayol;Laurent Poirel;Adrian Brink;Maria-Virginia Villegas

  • Prevalence of extended-spectrum β-lactamases in South America

    M.V. Villegas;J.N. Kattan;M.G. Quinteros;J.M. Casellas

  • Clinical and Microbiological Aspects of Linezolid Resistance Mediated by the cfr Gene Encoding a 23S rRNA Methyltransferase

    Cesar A. Arias;Cesar A. Arias;Martha Vallejo;Jinnethe Reyes;Diana Panesso

  • Dissemination of Acinetobacter baumannii Clones with OXA-23 Carbapenemase in Colombian Hospitals

    Maria Virginia Villegas;Juan Nicolas Kattan;Adriana Correa;Karen Lolans

  • Mecanismos de resistencia a los antibióticos en bacterias Gram negativas

    José David Tafur;Julián Andrés Torres;María Virginia Villegas

  • The epidemiology of carbapenemases in Latin America and the Caribbean

    Kevin Escandón-Vargas;Sergio Reyes;Sergio Gutiérrez;María Virginia Villegas

  • New developments in carbapenems.

    J.N. Kattan;M.V. Villegas;J.P. Quinn;J.P. Quinn

  • Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals

    Maria Virginia Villegas;Adriana Correa;Federico Perez;Maria Consuelo Miranda

Frequent Co-Authors

John P. Quinn
John P. Quinn AstraZeneca (United Kingdom)
Patrice Nordmann
Patrice Nordmann University of Fribourg
Cesar A. Arias
Cesar A. Arias The University of Texas Health Science Center at Houston
Laurent Poirel
Laurent Poirel University of Fribourg
Yehuda Carmeli
Yehuda Carmeli Tel Aviv University
Thierry Naas
Thierry Naas University of Paris-Saclay
Federico Perez
Federico Perez Case Western Reserve University
Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
Jean B. Patel
Jean B. Patel Centers for Disease Control and Prevention
Ana C. Gales
Ana C. Gales Federal University of Sao Paulo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Microbiology, exploring related online degrees can open diverse career opportunities in the healthcare and life sciences fields. For those seeking swift entry into the medical sector, programs like the quickest medical billing and coding certificate online offer a flexible, efficient pathway with strong job prospects.

Moreover, pursuing medical degrees online that pay well is a strategic move for microbiology graduates aiming to boost earning potential while advancing their expertise in health sciences. These degrees often integrate well with microbiological knowledge in fields like infectious disease and clinical research.

Public health also presents a natural extension, and students may consider easy MPH online programs for an accessible entry point into leadership roles in health policy and epidemiology. Such programs complement microbiology backgrounds and broaden public health impact.

Finally, specialized careers such as child life specialist, with a competitive child life specialist salary, offer unique opportunities to apply scientific knowledge alongside compassionate care, supporting children and families in healthcare settings.

Best Scientists Citing Maria Virginia Villegas

Trending Scientists

Recently Published Articles